Cargando…

Pancreaticoduodenectomy in optimal primary cytoreduction of epithelial ovarian cancer: A case report and review of the literature

• Aggressive multi-organ resection of epithelial ovarian cancer (EOC) at the time of primary cytoreduction improves patient survival. • We describe pancreaticoduodenectomy (Whipple procedure) as an efficacious tool for optimal cytoreduction in bulky upper abdominal EOC.

Detalles Bibliográficos
Autores principales:	Beissel, Joy M., Kendrick, Michael L., Podratz, Karl C., Bakkum-Gamez, Jamie N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2014
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4434149/ https://www.ncbi.nlm.nih.gov/pubmed/26075997 http://dx.doi.org/10.1016/j.gore.2014.09.001

Ejemplares similares

Can primary optimal cytoreduction be predicted in advanced epithelial ovarian cancer preoperatively?
por: Mousavi, Azam-Sadat, et al.
Publicado: (2010)

Splenectomy during cytoreductive surgery in epithelial ovarian cancer
por: Sun, Hengzi, et al.
Publicado: (2018)

Hepatobiliary Disease Resection in Patients with Advanced Epithelial Ovarian Cancer: Prognostic Role and Optimal Cytoreduction
por: Di Donato, Violante, et al.
Publicado: (2020)

Laparoscopic Cytoreduction for Primary Advanced Ovarian Cancer
por: Fanning, James, et al.
Publicado: (2010)

Prognostic Factors for Advanced Epithelial Ovarian Cancer Following Primary Cytoreductive Surgery or Neoadjuvant Chemotherapy
por: Nantasupha, Chalaithorn, et al.
Publicado: (2022)

Abdominopelvic inflammatory myofibroblastic tumor that metastasized to the vertebrae and liver: A case report and review of the literature
por: Kim, Sharon, et al.
Publicado: (2015)

Chemokine Ligand 5 to Predict Optimal Cytoreduction in Ovarian Cancer
por: Hidayat, Yudi Mulyana, et al.
Publicado: (2020)

Feasibility of laparoscopic cytoreduction in patients with localized recurrent epithelial ovarian cancer
por: Paik, E Sun, et al.
Publicado: (2016)

The role of CA-125, GLS and FASN in predicting cytoreduction for epithelial ovarian cancers
por: Winarno, G. N. A., et al.
Publicado: (2020)

Weekly induction intraperitoneal chemotherapy after primary surgical cytoreduction in patients with advanced epithelial ovarian cancer
por: Yu Zang, Rong, et al.
Publicado: (2006)

Prognostic influence of an early time to chemotherapy following primary cytoreductive surgery for advanced epithelial ovarian cancer
por: Eisenkop, Scott M., et al.
Publicado: (2022)

A case of pancreaticoduodenectomy and partial hepatic resection as repeat cytoreductive surgery for recurrent pseudomyxoma peritonei
por: Yamanaka, Kenya, et al.
Publicado: (2021)

Cytoreductive surgery in ovarian cancer
por: Pomel, Christophe, et al.
Publicado: (2007)

Cost-effectiveness of hyperthermic intraperitoneal chemotherapy at primary cytoreduction of epithelial ovarian cancer based on residual disease status
por: Penn, Courtney A., et al.
Publicado: (2022)

Preoperative serum levels of HE4 and CA125 predict primary optimal cytoreduction in advanced epithelial ovarian cancer: a preliminary model study
por: Feng, Li-yuan, et al.
Publicado: (2020)

Secondary cytoreductive surgery for recurrent epithelial ovarian carcinoma: proposal for patients selection
por: Onda, T, et al.
Publicado: (2005)

A predictive score for optimal cytoreduction at interval debulking surgery in epithelial ovarian cancer: a two- centers experience
por: Ghisoni, Eleonora, et al.
Publicado: (2018)

Is Optimal Cytoreduction Post Neoadjuvant Chemotherapy the Only Prognostic Factor in Advanced Ovarian Cancer?
por: Dhiman, Pravesh, et al.
Publicado: (2022)

Is Optimal Cytoreduction Post Neoadjuvant Chemotherapy the Only Prognostic Factor in Advanced Ovarian Cancer?
por: Dhiman, Pravesh, et al.
Publicado: (2022)

The Significance of Preoperative Computed Tomography for Predicting Optimal Cytoreduction in Advanced Ovarian Cancer
por: Stachs, Angrit, et al.
Publicado: (2020)

Mininvasive Cytoreduction Surgery plus HIPEC for Epithelial Ovarian Cancer: A Systematic Review
por: Ronsini, Carlo, et al.
Publicado: (2023)

A prospective comparison of perioperative morbidity in advanced epithelial ovarian cancer: Primary versus interval cytoreduction - experience from India
por: Ahmad, Sheikh Zahoor, et al.
Publicado: (2015)

Feasibility and outcome of primary laparoscopic cytoreductive surgery for advanced epithelial ovarian cancer: a comparison to laparotomic surgery in retrospective cohorts
por: Liang, Huamao, et al.
Publicado: (2017)

Prognostic Significance of Preoperative NLR, MLR, and PLR Values in Predicting the Outcome of Primary Cytoreductive Surgery in Serous Epithelial Ovarian Cancer
por: Kovács, Anna Rebeka, et al.
Publicado: (2023)

Role of reactive thrombocytosis after primary cytoreductive surgery in advanced ovarian cancer
por: Kim, Myeong-Seon, et al.
Publicado: (2022)

Assessment of published models and prognostic variables in epithelial ovarian cancer at Mayo Clinic
por: Hendrickson, Andrea Wahner, et al.
Publicado: (2015)

Cytoreductive Surgery Combined with Hyperthermic Intraperitoneal Intraoperative Chemotherapy in the Treatment of Advanced Epithelial Ovarian Cancer
por: Tentes, Antonios-Apostolos K., et al.
Publicado: (2012)

Distal pancreatectomy with splenectomy for the management of splenic hilum metastasis in cytoreductive surgery of epithelial ovarian cancer
por: Xiang, Libing, et al.
Publicado: (2016)

Evaluation of Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy for Stage III Epithelial Ovarian Cancer
por: Lei, Ziying, et al.
Publicado: (2020)

Explainable Artificial Intelligence for Prediction of Complete Surgical Cytoreduction in Advanced-Stage Epithelial Ovarian Cancer
por: Laios, Alexandros, et al.
Publicado: (2022)

The Use of Artificial Intelligence for Complete Cytoreduction Prediction in Epithelial Ovarian Cancer: A Narrative Review
por: Parpinel, Giulia, et al.
Publicado: (2023)

3D laparoscopy as a tertiary cytoreductive (TCR) surgery in infiltrating ureter recurrent epithelial ovarian cancer – case report and a mini-review of the literature
por: Szopiński, Tomasz, et al.
Publicado: (2018)

The Cytoreductive Effect of Radiotherapy for Small Cell Ovarian Carcinoma of the Pulmonary Type: A Case Report and Review of the Literature
por: Terada, Shuhei, et al.
Publicado: (2018)

Cytoreductive surgery for advanced stage ovarian cancer in the second trimester of pregnancy—a case report and literature review
por: Bacalbaşa, Nicolae, et al.
Publicado: (2020)

Trends in extent of surgical cytoreduction for patients with ovarian cancer
por: Wong, Deanna H., et al.
Publicado: (2021)

Ten years’ disease-free survival of advanced epithelial ovarian cancer treated by cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy: A case report and literature review
por: Zhang, Jue, et al.
Publicado: (2020)

Survival Effects of Cytoreductive Surgery for Refractory Patients after Neoadjuvant Chemotherapy in Advanced Epithelial Ovarian Cancer
por: Shin, Wonkyo, et al.
Publicado: (2020)

Long term survival of cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy in advanced epithelial ovarian cancer
por: Zhang, Jue, et al.
Publicado: (2021)

Integrated Clinical and Genomic Models to Predict Optimal Cytoreduction in High-Grade Serous Ovarian Cancer
por: Cardillo, Nicholas, et al.
Publicado: (2022)

Investigating the effect of optimal cytoreduction in the context of platinum sensitivity in high‐grade serous ovarian cancer
por: Cardillo, Nicholas, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_dp6u849lq2uhaohnqmmvh7eg8e